Download Free Special Report Medical Cannabis Latin America Caribbean Book in PDF and EPUB Free Download. You can read online Special Report Medical Cannabis Latin America Caribbean and write the review.

The Business Year's Special Report on Medical Cannabis in Latin America and the Caribbean is the second entry in our medical cannabis series, building upon our inaugural report on the Colombian market. While legislative progress did not move as rapidly as hoped in some markets, such as in Mexico, 2019 also witnessed other markets such as Brazil reaching long-awaited liberalization milestones. This 92-page report is a comprehensive examination of that progress and of the current investment climate throughout Latin America and the Caribbean. To understand how these developments are shaping local markets and global investor attitudes on the region, The Business Year sat down with the industry leaders, local entrepreneurs, regulatory administrators, government legislators, legal advisors, medical researchers and global investors that are driving medical cannabis forward.
Special Report: Medical Cannabis Latin America 2022 is an examination, through the words of sector leaders, of the current state of this growing industry across Latin America as progressive regulatory landscapes emerge and companies look to gain an early foothold.
Since 2012, The Business Year has been producing annual publications on the Colombian economy, gathering the thoughts of hundreds of top business leaders in the process. Now, we seek to take the spotlight to Colombia's Caribbean region to see what is behind the economic transformation witnessed there in recent years. This special report comes in a series of online publications focusing on a certain aspect or industry in one of our 35 global markets. Our reports are consumed by investors, analysts, and decision makers around the world.
In this challenging time for Spain and the world at large, we want to remind readers of the fundamental economic dynamics of the country in order to better assess its business environment. This publication is unique in that it provides a holistic and multisectoral view of development at a point of much political uncertainty, all amidst notable efforts to become a leader of Industry 4.0 in the European bloc. With information straight from the mouths of leaders and decision makers across the economy, it is a comprehensive guide to investment throughout the diverse and industrially-rich regions of Spain. The Business Year's country-specific publications, sometimes featuring over 150 face-to-face interviews, are among the most comprehensive annual economic publications available internationally. This 179-page publication covers finance, green economy, energy, industry, IT and telecoms, transport, real estate, construction, agriculture, education, health, tourism, and retail.
As Ecuador and the world at large grapple with the emerging challenge of the COVID-19 pandemic, it is important not to forget the fundamentals of the Ecuadorian economy and the success stories of 2019 and the start of 2020. We believe contained within these pages is an accurate, balanced account of the state of the Ecuadorian economy as of publication, told through the words of the dozens of top public- and private-sector figures. The Business Year's country-specific publications, sometimes featuring over 150 face-to-face interviews, are among the most comprehensive annual economic publications available internationally. This 212-page publication covers green economy, finance, hydrocarbons, mining, agriculture, construction, industry, transport, education, health, ICT, and tourism.
The 2019 World Drug Report will include an updated overview of recent trends on production, trafficking and consumption of key illicit drugs. The Report contains a global overview of the baseline data and estimates on drug demand and supply and provides the reference point for information on the drug situation worldwide.
This document examines the global and regional evolution of Foreign Direct Investment (FDI) and offers recommendations so these flows can contribute to the region's productive development processes.
Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.
In this book the author, an investigative journalist, traces the social history of marijuana from its origins to its emergence in the 1960s as a defining force in an ongoing culture war. He describes how the illicit marijuana subculture overcame government opposition and morphed into a multibillion-dollar industry. In 1996, Californians voted to legalize marijuana for medicinal purposes. Similar laws have followed in several other states, but not without antagonistic responses from federal, state, and local law enforcement. The author draws attention to underreported scientific breakthroughs that are reshaping the therapeutic landscape: medical researchers have developed promising treatments for cancer, heart disease, Alzheimer's, diabetes, chronic pain, and many other conditions that are beyond the reach of conventional cures. This book is an examination of the medical, recreational, scientific, and economic dimensions of the world's most controversial plant.